Article
In vitro susceptibility patterns for rapidly growing nontuberculous mycobacteria in the United States
15 Dec 2022
Abstract excerpt
Antimicrobial susceptibility testing for rapidly growing mycobacteria (RGM) is uncommon or only performed in large reference laboratories. Here we developed a cumulative antibiogram for 14 RGM using the largest sample size to date (N = 3860). All RGM showed 82% to 100% susceptibility to amikacin. Mycobacterium abscessus showed low percentages of susceptibility to most antimicrobials; of antimicrobials without...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
